IS5931A - Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi - Google Patents

Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi

Info

Publication number
IS5931A
IS5931A IS5931A IS5931A IS5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A
Authority
IS
Iceland
Prior art keywords
small virus
cell proliferation
coatings
cell migration
inhibit
Prior art date
Application number
IS5931A
Other languages
English (en)
Inventor
Broliden Kristina
Westgren Magnus
Original Assignee
Broliden Kristina
Westgren Magnus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broliden Kristina, Westgren Magnus filed Critical Broliden Kristina
Publication of IS5931A publication Critical patent/IS5931A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS5931A 1998-11-24 2001-05-02 Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi IS5931A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804022A SE520177C2 (sv) 1998-11-24 1998-11-24 Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
PCT/IB1999/002112 WO2000030668A2 (en) 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Publications (1)

Publication Number Publication Date
IS5931A true IS5931A (is) 2001-05-02

Family

ID=20413393

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5931A IS5931A (is) 1998-11-24 2001-05-02 Notkun smáveiruhjúphluta til að hamla frumufjölgun og frumuflutningi

Country Status (14)

Country Link
EP (1) EP1131085A2 (is)
JP (1) JP2003516927A (is)
KR (1) KR20010080518A (is)
CN (1) CN1328469A (is)
AU (1) AU2566600A (is)
CA (1) CA2352043A1 (is)
CZ (1) CZ20011369A3 (is)
HU (1) HUP0104298A2 (is)
IS (1) IS5931A (is)
MX (1) MXPA01004949A (is)
NO (1) NO20012534L (is)
PL (1) PL348640A1 (is)
SE (1) SE520177C2 (is)
WO (1) WO2000030668A2 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124523T2 (de) 2001-07-10 2007-09-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
EP1791858B1 (en) * 2004-09-24 2010-04-21 Intercell AG Modified vp1-capsid protein of parvovirus b19
CN101475942B (zh) * 2008-11-28 2012-05-23 中国人民解放军第四军医大学 一种b19病毒vp1独特区基因
US9598468B2 (en) 2011-05-18 2017-03-21 University Of Florida Research Foundation, Incorporated Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
NL8902301A (nl) * 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

Also Published As

Publication number Publication date
CZ20011369A3 (cs) 2001-10-17
JP2003516927A (ja) 2003-05-20
WO2000030668A3 (en) 2000-11-09
AU2566600A (en) 2000-06-13
CA2352043A1 (en) 2000-06-02
NO20012534L (no) 2001-06-29
WO2000030668A9 (en) 2001-04-05
PL348640A1 (en) 2002-06-03
CN1328469A (zh) 2001-12-26
EP1131085A2 (en) 2001-09-12
KR20010080518A (ko) 2001-08-22
SE9804022L (sv) 2000-05-25
WO2000030668A8 (en) 2000-09-14
HUP0104298A2 (hu) 2002-03-28
NO20012534D0 (no) 2001-05-23
SE520177C2 (sv) 2003-06-03
WO2000030668A2 (en) 2000-06-02
SE9804022D0 (sv) 1998-11-24
MXPA01004949A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
EE200000706A (et) Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
DE69930647D1 (de) Struktur-analoga von amin-basen und nucleosiden
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DE69924589D1 (de) Einphasige Silikon- und Wasserzusammensetzung
DK0810415T3 (da) Keramisk panserplade og fremgangsmåde til fremstilling heraf
DK383989A (da) Middel til modvirkning af dannelse af overtraek og dets anvendelse
NO20005100L (no) Genetisk modifiserte celler og fremgangsmåter for ekspresjon av rekombinant heparanase og fremgangsmåter for rensing av samme
DK349486D0 (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og deres anvendelse til behandling af pulmonale, allergiske, inflammatoriske og cardiovasculaere sygdomme
DE59902868D1 (de) Verwendung von ectoin oder ectoin-derivaten in formulierungen
DE69932024D1 (de) Rückwirkend kontrolliertes elektrochemisches Ablösen von Gasturbinen-Beschichtungen
DE69827942D1 (de) Leptin als inhibitor der tumorzellenproliferation
DK0915872T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
NO20014768D0 (no) Inhibitorer av LFA-1 binding til ICAM og anvemdelser derav
FI971934A7 (fi) Asyloituja bentsyyliglykosideja sileälihassolulisääntymisen inhibiittoreina
EP1039897A4 (en) COMPOUNDS BASED ON INADONE AND TETRALONE FOR INHIBITING CELL PROLIFERATION
DK1064279T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
KR950703064A (ko) 세포증식의 저해물질, 그의 제조방법 및 이용방법
DE69738735D1 (de) Mischungen aus interpolymeren von alpha-olefin-/vinylidenaromatischen monomeren und/oder gehinderten aliphatischen monomeren oder vinylidencycloaliphatischen monomeren
FI971936L (fi) Sileän lihaskudoksen solujen lisääntymisen estäjät
EE03871B1 (et) Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid
DE69737017D1 (de) Verwendung von energie-bursts in schnurlosen netzwerken
NO984156L (no) Belegging av por°se elektroder med tynne elekrotlyttlag
ATE341156T1 (de) Nummerierung von videobjekten und -zellen
DE69838482D1 (de) Verbesserungen von oder bezüglich telekommunikation